Savers Value Village (SVV) Insider Exercise and 10b5-1 Sale of 9,052 Shares
Rhea-AI Filing Summary
Richard A. Medway, General Counsel of Savers Value Village, Inc. (SVV), executed option exercises and sales on 09/24/2025. He exercised 9,052 options with an exercise price of $1.41 per share, converting them into the same number of common shares. Those 9,052 shares were then sold under a 10b5-1 trading plan at a weighted average price of $13.0415 per share (execution range $12.98–$13.20). After these transactions the reporting person held 0 shares of common stock directly and reported 384,256 shares of beneficial ownership (per the filing). The filing explains the option grant schedule and that some options are performance-based and time-based.
Positive
- Transaction disclosed under a 10b5-1 plan, indicating prearranged trading and enhanced compliance transparency
- Full exercise and sale details provided: exercise price ($1.41), weighted average sale price ($13.0415) and execution range ($12.98–$13.20)
- Filing explains vesting structure for options, including time-based and performance-based components
Negative
- Insider sale of 9,052 shares reduced direct common stock holdings to 0, which some investors may view unfavorably
Insights
TL;DR: Insider exercised vested options and promptly sold those shares under a prearranged 10b5-1 plan; reporting and disclosures appear complete.
The filing shows a routine option exercise and immediate sale of 9,052 shares executed under a 10b5-1 plan, with a disclosed weighted average sale price and price range. The options exercised carried a low exercise price ($1.41) relative to the sale price (~$13.04), indicating a substantial gain on those specific shares. The form also discloses the larger pool of beneficially owned shares (384,256) and clarifies vesting mix between time-based and performance-based awards. For investors, this is a standard insider liquidity event rather than an operational disclosure. Documentation of the 10b5-1 plan and price-range detail supports compliance and transparency.
TL;DR: Disclosure is clear about the 10b5-1 plan and option vesting; no governance red flags in the filing itself.
The Form 4 specifies the 10b5-1 adoption date (March 10, 2025), provides the weighted average sale price and execution range, and explains vesting mechanics for the underlying options (time-based and performance-based components). The reporting person signed the form and included explanatory notes on option origin and vesting, which aligns with best practices for insider transaction transparency. The immediate sale following exercise is disclosed and tied to the pre-existing plan, mitigating concerns about opportunistic trading based on nonpublic information as presented here.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Option (Right to Purchase) | 9,052 | $1.41 | $13K |
| Exercise | Common Stock | 9,052 | $1.41 | $13K |
| Sale | Common Stock | 9,052 | $13.0415 | $118K |
Footnotes (1)
- The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 10, 2025. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $12.98 to $13.20. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024. Approximately 16% represents time-based options which vested in substantially equal annual installments over five years starting March 28, 2020, and approximately 84% represents performance-based options, of which 25% vested upon the initial public offering and the remainder will be eligible for vesting upon satisfaction of certain performance criteria including stock price performance.